Literature DB >> 3196472

Neoplasms of the central nervous system in Norway. I. Quality control of the registration in the Norwegian Cancer Registry.

A Helseth1, F Langmark, S J Mørk.   

Abstract

The Norwegian Cancer registry includes reports on 8,933 cases of primary central nervous system neoplasms diagnosed in the period 1955-1984. Before submitting this data set to epidemiological analysis, errors were searched out and subsequently corrected, and a quality control was performed. First, seven categories of neoplasm records likely to be faulty were defined. In this way 109 cases (1.2% of the total) were identified for extensive study. Minor or major errors were found and corrected in 86 cases. The main source of error was misinterpretation of data by cancer registry staff (67 out of 109 cases). The second approach was to evaluate the quality of the corrected data set by a random draw of 300 cases. Errors concerning total incidence rates and rates for main groups of gliomas, meningiomas and neurilemmomas represented 0.3% of the total, and altogether 9.3% of errors of varying severity were revealed. The series is discussed with regard to prerequisites for serving as reliable data on CNS neoplasm epidemiology. The results indicate that the data from the Norwegian Cancer Registry is sufficiently valid for a thorough study of CNS neoplasms.

Entities:  

Mesh:

Year:  1988        PMID: 3196472     DOI: 10.1111/j.1699-0463.1988.tb00974.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  4 in total

Review 1.  Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results.

Authors:  C E Counsell; R Grant
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

2.  A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme.

Authors:  Pål A Rønning; Eirik Helseth; Torstein R Meling; Tom B Johannesen
Journal:  Neuro Oncol       Date:  2012-08-06       Impact factor: 12.300

3.  Diversity and biogeography of SAR11 bacteria from the Arctic Ocean.

Authors:  Susanne Kraemer; Arthi Ramachandran; David Colatriano; Connie Lovejoy; David A Walsh
Journal:  ISME J       Date:  2019-09-09       Impact factor: 10.302

4.  Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway.

Authors:  Espen Enerly; Freddie Bray; Christine Mellem; Bo Terning Hansen; Grete Kjølberg; Tove Dahl; Tom Børge Johannesen; Mari Nygård
Journal:  Acta Oncol       Date:  2011-11-02       Impact factor: 4.089

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.